17
Apr 25
IRIS Capital invests in SYNBIOTIC’s growth strategy
Düsseldorf, Germany– apr 17, 2025 – The European medical cannabis and industrial hemp group SYNBIOTIC SE and the venture capital company IRIS Capital Investment have entered into a strategic partnership. The French investment company will actively support SYNBIOTIC’s growth strategy. In a first phase, IRIS Capital Investment has decided and…